O’Ryan.health is a leader in at-home pediatric healthcare innovation. Our pioneering initiative is aimed at transforming pediatric autoimmune research and becoming the trusted brand in at-home pediatric blood sampling.

We are focused on delivering the best preventive cardio-information to enhance lifespan and quality of life.

Amazon FBA e-commerce store launched to sell products that help families have “Exceptional Experiences” with their children and pets.

We envision a world where patients with cancer receive an effective drug the first time. About 30% of patients have mutations in their DNA that indicate they'll respond well to certain drugs; we develop drugs for the other 70%. We combined our drug, NMI-900, with a unique diagnostic that measures RNA rather than DNA. Our approach has the potential to select the right patient, improve survival, and limit side effects. In 5 years, we look forward to regulatory approval in AML and helping patients.

Founded by a Palo Alto based venture accelerator to develop a Phase 1 precision therapy for cancers with defective mitochondria. Therapy out-licensed for a nationally recognized NCI designated Cancer Center.

Digital therapeutic and coaching company to help mid-life women through menopause. Product based on the successful treatment of >10,000 women at Beth Israel Hospital.

A group of parents, clinicians and scientists in Boston, Massachusetts, has formed the Mending Minds Foundation (MMF) to partner with world-class scientists in the hub of international research and discovery. Our goal is to support excellence in clinical care while providing sustainable funding of cutting-edge science to build the groundwork for understanding childhood immunopsychiatric conditions. This funding will be used to rapidly develop diagnostic tools and effective treatments, while disseminating information worldwide, to drive research to better understand and treat these difficult diseases.

FAPM2 was created in Miracopa County AZ to develop a re-usable biomanufacturing facility for the manufacturing of personalized treatment therapies developed at TGen

Life science advisor working with Precision Medicine Practice. Helped, established a new practice delivering biomedical strategy advisory services to life science ventures. Activities included practice planning; marketing material development; coordinating a national team of subject mater experts; preparation and delivery of client service; negotiation of fees & conditions; and producing client deliverables. Clients included venture backed startups, public life science companies, states governments, and academic medical centers.

BEAN was startup founded to create an electronic marketplace to buy and sell “revenue shares” to fund the development of mobile applications.

The Massey Cancer Center's mission to serve the Commonwealth of Virginia and the nation as an internationally recognized center of excellence in research, education, and patient care. Members are dedicated to improving the quality of human life through the development of effective means for the prevention, control, and ultimately the cure of cancer. The core of this mission is the facilitation of interdisciplinary cancer research to harness the significant scientific and clinical resources of Virginia Commonwealth University and the Medical College of Virginia.

BioCache Pharmaceuticals, Inc. is focused on becoming a leader in the development of proprietary immunotherapeutic products for the treatment and prevention of cancer. Responsibilities focused on securing institutional venture financing, directing the expansion of R&D activities of the core immunology technology, and developing multiple external relationships. Leadership in this role led to the recruitment of several high profile university collaborators and preparing for the transition to a clinical development firm.